From owner-watcher-work@jp.FreeBSD.org Thu Mar 28 21:54:48 2013
Received: (from daemon@localhost)
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) id r2SCsme71271;
	Thu, 28 Mar 2013 21:54:48 +0900 (JST)
	(envelope-from owner-watcher-work@jp.FreeBSD.org)
Received: from triband-mum-120.63.45.240.mtnl.net.in (triband-mum-120.63.45.240.mtnl.net.in [120.63.45.240])
	by castle.jp.FreeBSD.org (8.11.6p2+3.4W/8.11.3) with ESMTP/inet id r2SCsNJ71204;
	Thu, 28 Mar 2013 21:54:24 +0900 (JST)
	(envelope-from sonorouslo699@ahee-jewelers.com)
Received: from [120.63.45.240] (port=8590 helo=sachin)
	by ahee.com.s7b2.psmtp.com with asmtp 
	id 8D3B35-0002E8-49
	for <shiba@jp.freebsd.org>; Thu, 28 Mar 2013 18:23:22 +0530
Message-ID: <130C4CF7B51D4B36AAB06E6BB2008FC7@sachin>
From: "August Macias" <sonorouslo699@ahee-jewelers.com>
To: <shiba@jp.FreeBSD.org>
MIME-Version: 1.0
Content-Type: text/plain;
	format=flowed;
	charset="iso-8859-1";
	reply-type=original
Content-Transfer-Encoding: 7bit
X-Priority: 3
X-MSMail-Priority: Normal
X-Mailer: Microsoft Windows Mail 6.0.6001.18000
X-MimeOLE: Produced By Microsoft MimeOLE V6.0.6001.18049
X-Mras: Ok
Reply-To: watcher-work@jp.FreeBSD.org
Precedence: list
Date: Thu, 28 Mar 2013 18:23:22 +0530
X-Sequence: watcher-work 17472
Subject: [watcher-work 17472] Changing human lives for better
Sender: owner-watcher-work@jp.FreeBSD.org
X-Originator: sonorouslo699@ahee-jewelers.com
X-Distribute: distribute version 2.1 (Alpha) patchlevel 24e+060209

A pioneering biotech company creates extract formulations for various medical conditions, including more than 8 different types of Cancer.

Each individual one of these formulations has revenue and earnings potential in the hundreds of millions of dollars based on the current global pharmaceutical industry. The potential revenue and earnings are combined with additional profit centers including an educational model, nutraceutical products, and a strategic partnerships.

This is the only publicly traded company in existence that is involved in cannabinoid-extract based formulations. This model and leadership position is of great value as the company matures over the next twenty years and expands globally into a potential billion dollar biotech global leader.

In conclusion, a company is doing the right things, for the right reasons, with the right people, a company started by someone who was ill and found a way to heal themselves. That person shared their solution with others and they have shared with hundreds of millions of patients who are suffering; chronic pain patients, cancer patients, MS patients, soldiers and veterans with PTSD, those who are terminally ill, and patients with dozens of other conditions are now all aware of the medicinal value of cannabinoid. 

Now is simply the best opportunity for to help and heal those who are suffering through their formulations and services. If you are a leading industry investor with a passion to change human lives for better we welcome your support.

For more information, please visit:

www.sciencemttr.com

To opt-out, go to


www.optoutmepls.com

